Privacy Policy
Genentech, Inc. and Astellas Pharma US, Inc. respect the privacy of visitors to their websites, and we recognize your need for appropriate protection and management of personally identifiable information you share with us (any information by which you can be identified, including but not limited to, name, address, email address, and telephone number). That is why we have established the Privacy Policy for this website, so that you are informed about how we treat any personally identifiable information that you provide to us in the course of using this website. This Privacy Policy will inform you of:
- How you will be informed of updates to this Privacy Policy
- What personally identifiable information of yours we may collect from you through our website
- How we may use your personally identifiable information
- Limits on how we would share and disclose your personally identifiable information
- Our policy regarding links to third party websites
- Security of our website
- How you can correct and update your personally identifiable information
Please note that the Genentech, Inc. and Astellas Pharma US, Inc. websites are directed towards users who reside in the United States of America. It is not our intent to gather personally identifiable information from individuals residing outside the U.S.
Privacy Policy Updates
Due to the Internet's rapidly evolving nature, Genentech, Inc. and Astellas Pharma US, Inc. may need to update this Privacy Policy from time to time. If so, Genentech, Inc. and Astellas Pharma US, Inc. will post the updated Privacy Policy on our website located at www.tarceva.com so users are always aware of what personally identifiable information we may collect and how we may use this information. Genentech, Inc. and Astellas Pharma US, Inc. encourage you to review this Privacy Policy regularly for any changes. Your continued use of this website will be subject to the then-current Privacy Policy.
Information Collection and Use
You can generally visit our website without revealing any personally identifiable information about yourself. However, to access certain options and services we may ask you to provide certain personally identifiable information and without providing such personally identifiable information, you may be unable to access certain options and services. We (along with our third party partners engaged to provide marketing and advertising on our behalf) collect personally identifiable information about you only if you voluntarily provide it to us and you have the option not to provide any personally identifiable information to us. The following is personally identifiable information that you may voluntarily provide to us and how we use it:
- Surveys. Information obtained from you on web surveys, such as contact information (name and shipping address), demographic information (zip code, age level) and medical condition. We may use this personally identifiable information to provide you with information and services for which you have expressed an interest or that you may find useful based on your answers in a survey. Additionally, we may refer to your personally identifiable information to better understand your needs and how we can improve our website.
- Newsletters. Information obtained from you from your request to subscribe to a newsletter, such as contact information (name and email address). We may use this personally identifiable information to deliver the newsletters that you have elected to receive.
- Registration. Information obtained from you on registration forms used to process your requests for services and information, such as contact information (name, address, email address), password, username or code, age, date of birth, gender, ethnicity and medical condition. This registration information may also be gathered if you register for certain services via fax or mail. We may use this information to send you a welcoming email to verify your username and password, website updates, special offers, notices regarding relevant medical conditions and treatment, or other information responsive to the data that you provide to us. Additionally, we may refer to your personally identifiable information to better understand your needs and how we can improve our website.
- Email Content to a Friend. Information obtained from you regarding friend or family name and email address, if you elect to use our referral service for sending some of our website content to friends and family. We may use this personally identifiable information to automatically send the friend or family member a one-time email inviting them to visit the website. We may store this information for the sole purpose of sending this one-time email.
Genentech and Astellas Pharma US, Inc. are the owners of all information collected on this website.
Minors
You must be 18 years of age or older to submit registration or survey information. If you are under the age of 18 and wish to register to obtain further information or be included in a survey, then your parent or legal guardian must register to obtain the information or to participate in the survey.
Cookies and GIF files
Some of our websites may use cookie technology to identify users who have previously visited so the user is recognized upon return, thereby saving them time while on our website. A cookie is a piece of data stored on the user's hard drive containing information about the user. Usage of a cookie is in no way linked to any personally identifiable information while on our website. Once the user closes their browser, the cookie simply terminates. If a user rejects the cookie, they may still use our website. A cookie may be placed by us, or by vendors or service agencies who work with us or with our partners.
This website may use pixels, or transparent GIF files, to help manage online advertising. These GIF files are provided by our ad management partners. These files enable these partners to recognize a unique file on your web browser, which in turn enables us to learn which advertisements bring users to our website. The information contained in GIF files that we collect and share with our ad management partners is anonymous and is not personally identifiable.
Log Files and Aggregate Information
We may track the total number of visitors to our website, the number of visitors to each page of our website, IP addresses, and the domain names of our users' Internet Service Providers, and we may analyze these data for trends and statistics in the aggregate, but such information will be in aggregate form only and it will not contain personally identifiable data. Such aggregate information is not linked to any personally identifiable information that can identify any individual person.
We may use such aggregate information to analyze trends, administer the website, track user's movement, and gather broad demographic information for aggregate use. We may share this aggregate information with our corporate partners and contracted vendors to assist us in operating the website and to enable them to better understand Genentech's business.
Sharing and Disclosure
We may provide your personally identifiable information that we collect and the data generated by cookies to a parent, subsidiary or affiliate entity within the Genentech, Inc. and Astellas Pharma US, Inc. corporate family, partner entities, and the vendors and service agencies that we may engage to assist us. For example, we may provide your personally identifiable information to an organization in order to complete a service (e.g., send out newsletter emails you have requested), to assist us in reviewing the data or to provide marketing or advertising on our behalf. Any organization to which we provide such personally identifiable information is also required to keep your personally identifiable information confidential in accordance with this Privacy Policy. We will also disclose your personally identifiable information if we reasonably believe we are required to do so by law, regulation or other government authority (such as reporting safety information to the Food and Drug Administration). We will not sell your personally identifiable information to any other company or organization except we may transfer your personally identifiable information to a successor entity upon a merger, consolidation or other corporate reorganization in which Genentech, Inc. and Astellas Pharma US, Inc. participate or to a purchaser of all or substantially all of Genentech, Inc. and Astellas Pharma US, Inc.'s assets. Such successor entity shall be bound by the terms and conditions of this Privacy Policy.
Links to Third Party Sites
Some of our websites may contain links to other websites on the Internet that are not under the control of or maintained by Genentech, Inc. and Astellas Pharma US, Inc. Such links do not constitute an endorsement by Genentech, Inc. and Astellas Pharma US, Inc. of those other websites, the content displayed therein, or the persons or entities associated therewith. You acknowledge that Genentech, Inc. and Astellas Pharma US, Inc. are providing these links to you only as a convenience, and you agree that Genentech, Inc. and Astellas Pharma US, Inc. are not responsible for the content of such websites. Your use of these other linked websites is subject to the respective terms of use and privacy policies located on the linked websites.
Security
Genentech, Inc. and Astellas Pharma US, Inc. and their third party providers may employ procedural and technological security measures, consistent with industry practice. Such measures are reasonably designed to protect your personally identifiable information from loss, unauthorized access, disclosure, alteration or destruction. Genentech, Inc. and Astellas Pharma US, Inc. may use encryption, password protection, secure socket layers, internal restrictions and other security measures to help prevent unauthorized access to your personally identifiable information.
Correction/Updating Personally Identifiable Information
Genentech, Inc. and Astellas Pharma US, Inc. provide you with the ability to update the personally identifiable information that you have provided to us via Tarceva.com. You may "opt-out" of receiving emails from us to your current email address by using the unsubscribe feature on this site and included in the emails we send. To receive emails at a new email address, please re-subscribe to email updates with your new information.
Privacy Policy Last updated: July 2006
Tarceva in combination with gemcitabine is prescribed for patients with advanced-stage pancreatic cancer whose cancer has spread, grown, or cannot be surgically removed, and who have not received previous chemotherapy.
There have been reports of serious events involving the lungs in a small number of patients taking Tarceva. These events have included death in some patients. The medical name for these types of events is interstitial (in-tur-STISH-ul) lung disease-like events (or ILD-like events).
Liver and/or kidney problems (including deaths) have been reported in some patient taking Tarceva. Let your healthcare provider (HCP) know if you have a history of liver or kidney disease.
Some patients taking Tarceva have developed a hole in the lining of their stomach or intestines (including deaths). It may happen more in patients who are taking certain other medicines or who have certain stomach and intestinal diseases.
Some patients taking Tarceva have developed serious skin conditions. Some patients have died from these conditions.
Patients taking Tarceva plus gemcitabine were more likely to experience bleeding and clotting problems such as heart attack or stroke.
Some patients taking Tarceva have developed eye irritation and damage to the cornea. The cornea is the clear part of the eyeball that covers the colored part of the eye and the pupil. Other eye problems such as abnormal eyelash growth, dry eyes, or changes in eyesight have also been reported.
Patients should tell their HCP about eye problems that get worse. Including eye pain.
Women should not become pregnant while on treatment with Tarceva. If you are already pregnant or become pregnant while taking Tarceva, you should talk with your HCP about the benefits and risks of continuing to take Tarceva.
DO NOT breast-feed while receiving treatment with Tarceva.
Call your HCP right away if you have these signs or symptoms:
- New or worsening skin rash
- Serious or ongoing diarrhea, nausea, loss of appetite, or vomiting
- New or worsening shortness of breath or cough
- Eye irritation
Some patients taking Tarceva have experienced difficulty with blood clotting, and bleeding events, including gastrointestinal and non-gastrointestinal bleeding. Patients taking blood thinners (Coumadin®, warfarin or other coumarin-derivatives) should be monitored regularly.
Certain medicines and herbal supplements can affect how Tarceva works for in the body. It is important that you tell your HCP about all of the medicines and herbal supplements you are taking. DO NOT start taking any new medicines or herbal supplements before talking with your HCP. Tarceva may also affect other medications you are taking.
In addition, grapefruit and grapefruit juice have an effect on how Tarceva works. DO NOT eat grapefruit or drink grapefruit juice while on treatment with Tarceva, except under the care of your HCP.
Smoking may affect how well Tarceva works for you. If you smoke, you should stop smoking before starting treatment with Tarceva. Talk with your HCP about how to quit smoking. If you continue to smoke, you should talk with your HCP before taking Tarceva.
The most common side effects in patients who took Tarceva plus gemcitabine were fatigue “feeling tired”, rash, nausea, loss of appetite, and diarrhea. Other skin changes may also be seen.
The rash from Tarceva plus gemcitabine therapy may appear on your upper body or face. Typically rash occurs within 10 days of starting treatment, but it may occur any time during treatment.
The rash is not an allergic reaction. It may look like acne or dry skin. It is not acne. Talk to your HCP if a rash occurs.
Typically, diarrhea may develop within 15 days of starting Tarceva plus gemcitabine therapy.
Hair and nail changes have been seen with Tarceva.
Always let your HCP know if you have any side effects, and ask about the best way to handle them.
Tarceva is not right for everyone. Ask your HCP if once-daily Tarceva is right for you.
